A JAMA study has found that hemoglobin A1C measurements — a biomarker frequently used to diagnose diabetes — may be less accurate in African-Americans with sickle cell trait.
A Northwestern Medicine study has established a new safety index for a common group of chemotherapy drugs, by using a stem cell model to screen such therapies for cardiotoxicity.
First-year medical students explored the applied arts during a five-week seminar in medical humanities and bioethics.
A panel of experts gathered to discuss strategies for preventing violence among young men in Chicago, at an event sponsored by the Institute for Public Health and Medicine and the Office of Diversity and Inclusion.
Medical students in the Fein Yarns and Healing Threads student group work with patients at the Rehabilitation Institute of Chicago on their fine motor skills through knitting, and making baby hats for underserved patient populations.
A recent study, published in the New England Journal of Medicine, found a newer left ventricular assist device performed at least as well as existing devices on the market for patients with advanced heart failure.
Sandra Sanguino, ’93 MD, MPH, associate dean for Student Affairs, has received the Exceptional Mentor Award from the American Medical Women’s Association.
A phase 1 clinical trial of venetoclax and rituximab combination therapy was shown to be an effective chemo-free treatment option for patients with difficult-to-treat chronic lymphocytic leukemia.
A newly identified biomarker may predict treatment response in patients with chronic myelogenous leukemia, according to a Northwestern Medicine study.
As part of their community health project, first-year medical students presented on the barriers populations in different Chicago neighborhoods face to lead healthy lives.